AI assistant
BIO-RAD LABORATORIES, INC. — Director's Dealing 2021
Sep 3, 2021
30786_dirs_2021-09-03_57477539-b91f-462d-b971-1e94fe0c861f.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: BIO-RAD LABORATORIES, INC. (BIO BIOB)
CIK: 0000012208
Period of Report: 2021-09-01
Reporting Person: SCHWARTZ NORMAN D (Director, Chairman, President, and CEO, 10% Owner)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2021-09-02 | Bio-Rad A Common Stock | M | 1805 | — | Acquired | 420776 | Direct |
| 2021-09-02 | Bio-Rad A Common Stock | F | 895 | $825.77 | Disposed | 419881 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2021-09-01 | Restricted Stock Units | $0 | A | 5064 | Acquired | Bio-Rad A Common Stock (5064) | Direct | |
| 2021-09-01 | Non-Qualified Stock Option (right to buy) | $814.95 | A | 5064 | Acquired | 2031-09-01 | Bio-Rad A Common Stock (5064) | Direct |
| 2021-09-02 | Restricted Stock Units | $0 | M | 1805 | Disposed | Bio-Rad A Common Stock (1805) | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Bio-Rad B Common Stock | 12838 | Indirect |
| Bio-Rad B Common Stock | 4060054 | Indirect |
| Bio-Rad B Common Stock | 298274 | Direct |
Footnotes
F1: Shares of Class A common stock acquired on the vesting of restricted stock units.
F2: The reporting person disclaims beneficial ownership of these shares.
F3: The shares are held by a limited partnership of which the reporting person is a limited and general partner. The reporting person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein.
F4: Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock.
F5: The restricted stock units vest over four years at 25% per year on the yearly anniversary date of the grant.
F6: The stock option vests over four years at 25% per year on the yearly anniversary date of the grant.
F7: On September 2, 2020, the reporting person was granted 7,220 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date.